Solasto Past Earnings Performance

Past criteria checks 0/6

Solasto's earnings have been declining at an average annual rate of -12.6%, while the Healthcare industry saw earnings growing at 6.4% annually. Revenues have been growing at an average rate of 8.7% per year. Solasto's return on equity is 1.4%, and it has net margins of 0.2%.

Key information

-12.6%

Earnings growth rate

-12.7%

EPS growth rate

Healthcare Industry Growth7.9%
Revenue growth rate8.7%
Return on equity1.4%
Net Margin0.2%
Next Earnings Update12 Feb 2025

Recent past performance updates

Investors Can Find Comfort In Solasto's (TSE:6197) Earnings Quality

Nov 19
Investors Can Find Comfort In Solasto's (TSE:6197) Earnings Quality

Recent updates

Solasto's (TSE:6197) Dividend Will Be ¥10.00

Nov 26
Solasto's (TSE:6197) Dividend Will Be ¥10.00

Investors Can Find Comfort In Solasto's (TSE:6197) Earnings Quality

Nov 19
Investors Can Find Comfort In Solasto's (TSE:6197) Earnings Quality

Here's What Analysts Are Forecasting For Solasto Corporation (TSE:6197) After Its Interim Results

Nov 14
Here's What Analysts Are Forecasting For Solasto Corporation (TSE:6197) After Its Interim Results

Why Investors Shouldn't Be Surprised By Solasto Corporation's (TSE:6197) 29% Share Price Surge

Sep 04
Why Investors Shouldn't Be Surprised By Solasto Corporation's (TSE:6197) 29% Share Price Surge

Solasto (TSE:6197) Will Pay A Dividend Of ¥10.00

Aug 13
Solasto (TSE:6197) Will Pay A Dividend Of ¥10.00

There May Be Reason For Hope In Solasto's (TSE:6197) Disappointing Earnings

May 21
There May Be Reason For Hope In Solasto's (TSE:6197) Disappointing Earnings

Revenue & Expenses Breakdown

How Solasto makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

TSE:6197 Revenue, expenses and earnings (JPY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 24136,54430213,9010
30 Jun 24136,317-28016,1680
31 Mar 24135,1392,25714,5930
31 Dec 23133,6864,90314,6180
30 Sep 23132,9315,21014,4180
30 Jun 23131,9525,65413,9840
31 Mar 23131,0883,17213,6930
31 Dec 22128,4242,96713,8890
30 Sep 22124,2293,22013,5220
30 Jun 22120,2033,34013,2650
31 Mar 22117,2393,50212,7440
31 Dec 21115,3193,94012,5050
30 Sep 21113,9723,89012,2840
30 Jun 21110,3173,98611,7480
31 Mar 21106,1823,53811,5120
31 Dec 20102,4103,58612,1840
30 Sep 2099,0183,48611,8020
30 Jun 2097,3423,22711,6420
31 Mar 2095,7194,73911,5350
31 Dec 1993,4304,91611,4260
30 Sep 1990,2814,90511,1480
30 Jun 1987,1094,82310,7970
31 Mar 1984,2513,50610,1260
31 Dec 1882,2323,3639,7890
30 Sep 1880,0973,0839,4930
30 Jun 1877,3812,9149,1300
31 Mar 1874,3292,7108,7920
31 Dec 1771,0672,6498,4510
30 Sep 1768,4302,6257,9970
30 Jun 1766,7972,5827,6670
31 Mar 1765,4132,4737,5120
31 Dec 1664,5602,2117,3120
31 Mar 1663,0701,9937,2920
31 Mar 1560,1811,4517,0150
31 Mar 1458,4232,3947,2550

Quality Earnings: 6197 has a large one-off loss of ¥3.9B impacting its last 12 months of financial results to 30th September, 2024.

Growing Profit Margin: 6197's current net profit margins (0.2%) are lower than last year (3.9%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 6197's earnings have declined by 12.6% per year over the past 5 years.

Accelerating Growth: 6197's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 6197 had negative earnings growth (-94.2%) over the past year, making it difficult to compare to the Healthcare industry average (8.3%).


Return on Equity

High ROE: 6197's Return on Equity (1.4%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies